Overview

ATLAS Study

ATLAS (A Prospective, Multi-Center Trial of a Long-term Bio-Absorbable Mesh with Sepra Technology in Challenging Laparoscopic Ventral or Incisional Hernia Repair)

Objective

This study is enrolling patients from Proliance Surgical Specialists at Overlake located in the Overlake Medical Pavilion.  The Food and Drug Administration (FDA) cleared Phasix™ ST Mesh for sale in the United States for the reinforcement of soft tissue, including hernia repair.  Looking to gain further insight about the outcomes of each patient, this study follows patients for 2 years after surgery.

 

Study Coordinator(s)

Kim Glorieux, CRC

Phone: 425.635.6082

Kimberly.Glorieux@overlakehospital.org

 

Tina Fortney, RN BSN CCRC

Phone: 425.688.5407

Tina.fortney@overlakehospital.org

 

Clinical Trial Categories

Surgical

View all hospital services

Make a gift

Need urgent care?